Skip to content
User

Sarah Ketterer

Causeway Capital Management

Sarah Ketterer Xtrackers Harvest CSI 300 China A-Shares ETF stake

total: 372

Causeway Capital Management ASHR trades

Total transactions:
28
New positions:
3
Sold out:
3
Added:
14
Reduced:
8
Held since:
2025 Q4
Held for:
1 quarter
Latest activity:
2026 Q1
According to 2026 Q2 report, Sarah Ketterer doesn't hold any Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) shares. To date, the estimated cost basis is nearly $32.85 for "buy" trades and estimated average "sell" price is $32.85. Causeway Capital Management first purchased ASHR in 2018 Q2, initially acquiring 34,000 shares. Sarah Ketterer later completely sold out the position and invested in Xtrackers Harvest CSI 300 China A-Shares ETF again in 2025 Q4. Since the initial investment in Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR), Causeway Capital Management has made 27 more transactions.

When did Sarah Ketterer sell Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)?

Sarah Ketterer sold off the entire Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) position in 2026 Q1.

When did Sarah Ketterer buy Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)?

Sarah Ketterer first invested in Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) in 2018 Q2 at the reported quarter-end price of $26.53 per share.

What's the cost basis of Causeway Capital Management's ASHR stake?

The estimated cost basis for Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) stake is around $32.85 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$32.85
Weighted AVG sell price:
$32.85

Sarah Ketterer's historical trades in Xtrackers Harvest CSI 300 China A-Shares ETF

28 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q1
0.00%
0
$32.85
-100% (-28,800)
-0.01%
2025 Q4
0.01%
28,800
$32.85
$946,080
new
+0.01%
2024 Q4
0.00%
0
$28.59
-100% (-584,659)
-0.41%
2024 Q3
0.41%
584,659
$28.59
$16,715,401
+2.27% (+12,985)
+0.01%
2024 Q2
0.37%
571,674
$23.57
$13,474,356
+13.85% (+69,543)
+0.04%
2024 Q1
0.32%
502,131
$24.07
$12,086,293
+18.55% (+78,557)
+0.05%
2023 Q4
0.26%
423,574
$23.91
$10,127,654
-19.98% (-105,739)
-0.07%
2023 Q3
0.36%
529,313
$26.01
$13,767,431
+12.31% (+58,010)
+0.04%
2023 Q2
0.33%
471,303
$26.76
$12,612,068
-17.16% (-97,605)
-0.06%
2023 Q1
0.40%
568,908
$29.48
$16,771,408
-10.15% (-64,283)
-0.06%
2022 Q4
0.52%
$28.02
-7.06% (-48,105)
2022 Q3
0.52%
$27.09
new
2022 Q2
0.00%
$33.09
-100% (-719,923)
2022 Q1
0.57%
$33.09
+9.69% (+63,586)
2021 Q4
0.56%
$39.09
+7.01% (+42,972)
2021 Q3
0.53%
$38.11
-10.99% (-75,713)
2021 Q2
0.57%
$40.54
-4.34% (-31,243)
2021 Q1
0.55%
$38.62
+8.93% (+59,027)
2020 Q4
0.50%
$40.06
-0.17% (-1,108)
2020 Q3
0.42%
$34.48
-6.50% (-46,077)
2020 Q2
0.38%
$29.71
+27.66% (+153,500)
2020 Q1
0.23%
$25.89
+2.19% (+11,900)
2019 Q4
0.17%
$29.64
+23.77% (+104,282)
2019 Q3
0.14%
$27.09
+19.97% (+73,047)
2019 Q2
0.11%
$28.16
+95.37% (+178,543)
2019 Q1
0.05%
$28.73
+156.80% (+114,307)
2018 Q3
0.02%
$25.35
+114.41% (+38,900)
2018 Q2
0.01%
$26.53
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.